US2009104694A1PendingUtilityA1

Isolation and transplantation of retinal stem cells

Assignee: SCHEPENS EYE RES INSTPriority: Feb 11, 2000Filed: Nov 6, 2008Published: Apr 23, 2009
Est. expiryFeb 11, 2020(expired)· nominal 20-yr term from priority
A61P 31/00A61P 29/00A01K 67/0271C12N 5/0623C12N 2501/135C12N 2501/115C12N 5/0621C12N 2506/02C12N 2501/11A61P 27/02A61K 35/12
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the isolation, in vitro propagation, and transplantation and integration of non-pigmented retinal stem cells derived from the neuroretina of the eye, ex vivo and in vivo.

Claims

exact text as granted — not AI-modified
1 . Retinal stem cells isolated from a neuroretina of a donor mammal. 
   
   
       2 . Retinal stem cells isolated from a neuroretina of a donor mammal, being capable of:
 a) self-renewal in vitro;   b) differentiating into any one cell type of the group consisting of neurons, astrocytes, and oligodendrocytes;   c) integration into a host retina when grafted on the host retina; and   d) differentiation into photoreceptor cells when grafted onto a retina, onto a retinal explants, or into a mature eye.   
   
   
       3 . The retinal stem cells of  claim 1  or  2 , wherein the retinal stem cells express nestin and are non-pigmented. 
   
   
       4 . The retinal stem cells of  claim 1  or  2 , said cells requiring, when cultured in vitro, the presence at least one exogenous growth factor in a culture medium in order to proliferate. 
   
   
       5 . The retinal stem cells of  claim 4 , wherein at least one exogenous growth factor is a member selected from the group consisting of epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), a combination of bFGF and EGF, and a combination of EGF and bFGF and platelet-derived growth factor (PDGF). 
   
   
       6 . The retinal stem cells of  claim 1  or  2 , which can differentiate into neurons, as evidenced by expression of a neurofilament protein, NF-200. 
   
   
       7 . The retinal stem cells of  claim 1  or  2 , which can differentiate into astrocytes, as evidenced by expression of glial fibrillary acidic protein, GFAP. 
   
   
       8 . The retinal stem cells of  claim 1  or  2 , which, when grafted onto a retina, onto a retinal explants, or into a mature eye, differentiate into photoreceptor cells expressing rhodopsin, recoverin, or both. 
   
   
       9 . The retinal stem cells of  claim 8 , further being capable of integrating into and repopulating a diseased retina. 
   
   
       10 . The retinal stem cells of  claim 1  or  2 , wherein the mammal is an embryo, a neonate, or an adult. 
   
   
       11 . The retinal stem cells of  claim 1  or  2 , wherein the mammal is a primate, a rodent, or a domesticated animal. 
   
   
       12 . The retinal stem cells of  claim 1  or  2 , wherein the mammal is a human, a mouse, a rat, a cat, a dog, a pig, a cow, a horse, a monkey, or a great ape. 
   
   
       13 - 24 . (canceled) 
   
   
       25 . The neuroretina-derived retinal stem cells of  claim 1  or  2 , wherein the mammal was is a transgenic mouse expressing green fluorescent protein. 
   
   
       26 . The neuroretina-derived retinal stem cells of  claim 1  or  2 , being clonally derived. 
   
   
       27 - 45 . (canceled) 
   
   
       46 . The retinal stem cells of  claim 1  which are derived from a neurosphere.

Join the waitlist — get patent alerts

Track US2009104694A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.